First Page | Document Content | |
---|---|---|
Date: 2015-01-13 16:08:30Biotechnology Prostate cancer Prostate-specific antigen Prostate Cancer Minimal residual disease PCA3 Prostate cancer screening Medicine Biomarkers Tumor markers | ClinChem200905_Bruns-glucoseAdd to Reading ListSource URL: www.aacc.orgDownload Document from Source WebsiteFile Size: 64,16 KBShare Document on Facebook |
Biotechnology, BS "DBEFNJD.BQ 5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBTDocID: 1xTqy - View Document | |
PDF DocumentDocID: 1wroO - View Document | |
Building A Better Mousetrap: Patenting Biotechnology In The European CommunityDocID: 1vr7C - View Document | |
BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prodDocID: 1vq6b - View Document | |
Biotechnology Consultation Agency Response Letter BNFDocID: 1vpUZ - View Document |